No Barrier To Predictive Testing Found In Breast Cancer Heterogeneity
 

Breast cancers contain many different cell types with different patterns of gene expression, but a new study provides reassurance that this variability should not be a barrier to using gene expression tests to help tailor cancer treatments to individual patients. The findings were reported at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium...

More...